Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Wednesday, October 26, 2011
Preclinical CRO will globally market services and capabilities together with genomics services provider for development novel drugs and medical devices
BEDFORD, MASS., and PALM BEACH GARDENS, FLA. - Toxikon,a preclinical contract research ...
read more
Wednesday, October 26, 2011
To provide a more comprehensive and efficient global solution for its laboratory customers, Quintiles today announced the signing of a definitive agreement to acquire Advion BioServices, a premier U.S.-based bioanalytical laboratory providing Good ...
read more
Monday, November 07, 2011
Quintiles’ ability to provide customers with actionable early-stage data to make better development decisions faster has taken a significant step forward with the closing of the previously announced agreement to acquire Advion BioServices, a premier ...
read more
Thursday, February 09, 2012
Almac is pleased to announce the doubling of analytical capacity at its 240,000 sq. ft. North American Headquarters. The facility, built on a 40 acre site in Souderton, PA, north of Philadelphia, and occupied since 2010, delivers full-service, ...
read more
Friday, February 17, 2012
Catalent Pharma Solutions today announced that it has completed the acquisition of the Clinical Trial Supplies business of Aptuit LLC. The acquisition substantially expands Catalent’s Development & Clinical Services business, transforming it into the...
read more
Tuesday, February 28, 2012
ICON plc, a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today announced the acquisition of PriceSpective LLC, a global leader in value strategy consulting. The acquisition ...
read more
Somerset, NJ – March 15, 2012 – Catalent Pharma Solutions, a leading global industry partner in product development, delivery and supply has extensive expertise in bringing more products to more markets around the world and will present a series of ...
read more
Evans Analytical Group, Inc. (EAG), the world’s leading, fully integrated, independent laboratory network, providing high value expert analytical and testing services to a wide range of industries and end users, today announced that it has acquired ...
read more
Wednesday, April 11, 2012
As more and more R&D is outsourced by pharmaceutical companies, a study released today provides new insight into how to structure the relevant partnerships for success.
read more
Worldwide Clinical Trials Inc., a leading global provider of clinical research services, today acknowledged receipt of strong ratings and recommendations from one of the industry’s leading independent market research firms, Industry Standard Research...
read more
Life Technologies (NASDAQ: LIFE) announced a major expansion of the existing manufacturing facilities at its European, Middle East and Africa headquarters at Inchinnan near Glasgow.
read more
ICON (NASDAQ: ICLR) (ISIN:IE0005711209), a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today reported its financial results for the first quarter ended March 31, 2012.
read more
ACM Global Central Lab, the central laboratory that continually defines the customer-service standard with its flexible approach, has advanced its hybrid central lab model in Mumbai with a state-of-the art operational facility dedicated to manage ...
read more
SeraCare Life Sciences, a global life sciences company providing vital products and services to facilitate the discovery, development and production of human diagnostics and therapeutics, today announced that Charlie Mamrak joined the company as CEO ...
read more
Wednesday, April 25, 2012
Southern Research today announced that it has signed an agreement with Apath, LLC which will allow Southern Research to conduct laboratory testing, research, and/or screening of potential therapeutic agents for hepatitis C (HCV) on an exclusive, fee...
read more